LEADER 01229aam 2200361I 450 001 9910709574903321 005 20151026032102.0 024 8 $aGOVPUB-C13-e9a6d4a032c4fb1d9af429f4b80881a1 035 $a(CKB)5470000002479250 035 $a(OCoLC)926731868 035 $a(EXLCZ)995470000002479250 100 $a20151026d1954 ua 0 101 0 $aeng 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aBiennial report $eNational Bureau of Standards /$fNational Bureau of Standards 210 1$aGaithersburg, MD :$cU.S. Dept. of Commerce, National Institute of Standards and Technology,$d1954. 215 $a1 online resource 225 1 $aNational Bureau of Standards miscellaneous publication ;$v213 300 $a1954. 300 $aContributed record: Metadata reviewed, not verified. Some fields updated by batch processes. 300 $aTitle from PDF title page. 320 $aIncludes bibliographical references. 517 $aBiennial report 712 02$aUnited States.$bNational Bureau of Standards. 801 0$bNBS 801 1$bNBS 801 2$bGPO 906 $aBOOK 912 $a9910709574903321 996 $aBiennial report$91929048 997 $aUNINA LEADER 02128nam 2200553 450 001 9910827778303321 005 20230803030851.0 010 $a1-60805-175-7 035 $a(CKB)2670000000400500 035 $a(EBL)1310827 035 $a(OCoLC)854975263 035 $a(SSID)ssj0001169902 035 $a(PQKBManifestationID)11960264 035 $a(PQKBTitleCode)TC0001169902 035 $a(PQKBWorkID)11168382 035 $a(PQKB)10290500 035 $a(MiAaPQ)EBC1310827 035 $a(Au-PeEL)EBL1310827 035 $a(CaPaEBR)ebr10756234 035 $a(EXLCZ)992670000000400500 100 $a20111102d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aTreatise on ocular drug delivery /$feditor, Ashim K. Mitra 210 1$aSharjah, United Arab Emirates ;$aOak Park, Illinois :$cBentham Science Publishers,$d[2013] 210 4$dİ2013 215 $a1 online resource (301 p.) 300 $aDescription based upon print version of record. 311 $a1-60805-347-4 320 $aIncludes bibliographical references and index. 327 $aCover; Title; EUL; Contents; Foreword; Preface; List of Contributors; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; Chapter 08; Chapter 09; Chapter 10; INDEX 330 $aThis monograph covers a range of topics on ocular pharmacology, such as the biochemical background of specific eye diseases, challenges for ocular drug delivery, the role of influx and efflux transporters, novel drug delivery systems, pharmacokinetics, regulatory aspects, and patenting opportunities for researchers. 606 $aDrug delivery systems 606 $aEye$xDiseases$xTreatment 615 0$aDrug delivery systems. 615 0$aEye$xDiseases$xTreatment. 676 $a617.7 676 $a617.7061 701 $aMitra$b Ashim K.$f1954-$01634726 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910827778303321 996 $aTreatise on ocular drug delivery$94049256 997 $aUNINA